secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2026-05-29T20:05:17+00:00
Accession:  0001213900-26-062802
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics issues $750K convertible note at 10% interest, convertible at $0.05 floor
--------------------------------------------------------------------------------

- Issued $750K convertible promissory note ($937.5K face value) to SRX Health Solutions, maturing May 28, 2027.
- Note bears 10% interest; conversion price is lesser of $0.05 or 80% of average 5 lowest intraday prices in prior 20 days.
- Company must file resale registration statement for shares issuable upon conversion; beneficial ownership cap of 4.99% applies.
- Issuance exempt under Section 4(a)(2) and Rule 506(b); lender is accredited investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/0001213900-26-062802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/ea0292715-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-062802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer